| Advances in PEGylation of important biotech molecules: delivery aspects SM Ryan, G Mantovani, X Wang, DM Haddleton, DJ Brayden Expert opinion on drug delivery 5 (4), 371-383, 2008 | 383 | 2008 |
| Binding and uptake of biodegradable poly-DL-lactide micro-and nanoparticles in intestinal epithelia S McClean, E Prosser, E Meehan, D O'Malley, N Clarke, Z Ramtoola, ... European Journal of Pharmaceutical Sciences 6 (2), 153-163, 1998 | 331 | 1998 |
| Expression of specific markers and particle transport in a new human intestinal M-cell model E Gullberg, M Leonard, J Karlsson, AM Hopkins, D Brayden, AW Baird, ... Biochemical and biophysical research communications 279 (3), 808-813, 2000 | 311 | 2000 |
| In Vitro Models of the Intestinal Barrier: The Report and Recommendations of ECVAM Workshop 46, E Le Ferrec, C Chesne, P Artusson, D Brayden, G Fabre, P Gires, ... Alternatives to laboratory animals 29 (6), 649-668, 2001 | 310 | 2001 |
| Intestinal permeation enhancers for oral peptide delivery S Maher, RJ Mrsny, DJ Brayden Advanced drug delivery reviews 106, 277-319, 2016 | 307 | 2016 |
| Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting DJ Brayden, MA Jepson, AW Baird Drug discovery today 10 (17), 1145-1157, 2005 | 282 | 2005 |
| Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials TAS Aguirre, D Teijeiro-Osorio, M Rosa, IS Coulter, MJ Alonso, ... Advanced drug delivery reviews 106, 223-241, 2016 | 276 | 2016 |
| Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic S Maher, TW Leonard, J Jacobsen, DJ Brayden Advanced drug delivery reviews 61 (15), 1427-1449, 2009 | 252 | 2009 |
| Antibacterial effects of poly (2-(dimethylamino ethyl) methacrylate) against selected gram-positive and gram-negative bacteria LAB Rawlinson, SM Ryan, G Mantovani, JA Syrett, DM Haddleton, ... Biomacromolecules 11 (2), 443-453, 2010 | 241 | 2010 |
| Drug delivery to inflamed colon by nanoparticles: comparison of different strategies R Coco, L Plapied, V Pourcelle, C Jérôme, DJ Brayden, YJ Schneider, ... International journal of pharmaceutics 440 (1), 3-12, 2013 | 192 | 2013 |
| Targeting polymerised liposome vaccine carriers to intestinal M cells MA Clark, H Blair, L Liang, RN Brey, D Brayden, BH Hirst Vaccine 20 (1-2), 208-217, 2001 | 172 | 2001 |
| Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10) C Twarog, S Fattah, J Heade, S Maher, E Fattal, DJ Brayden Pharmaceutics 11 (2), 78, 2019 | 158 | 2019 |
| Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches DJ Brayden, TA Hill, DP Fairlie, S Maher, RJ Mrsny Advanced drug delivery reviews 157, 2-36, 2020 | 154 | 2020 |
| Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route … MA Conway, L Madrigal-Estebas, S McClean, DJ Brayden, KHG Mills Vaccine 19 (15-16), 1940-1950, 2001 | 153 | 2001 |
| Direct peptide bioconjugation/PEGylation at tyrosine with linear and branched polymeric diazonium salts MW Jones, G Mantovani, CA Blindauer, SM Ryan, X Wang, DJ Brayden, ... Journal of the American Chemical Society 134 (17), 7406-7413, 2012 | 146 | 2012 |
| Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET™ TW Leonard, J Lynch, MJ McKenna, DJ Brayden Expert opinion on drug delivery 3 (5), 685-692, 2006 | 145 | 2006 |
| Controlled release technologies for drug delivery DJ Brayden Drug discovery today 8 (21), 976-978, 2003 | 138 | 2003 |
| Oral vaccination in man using antigens in particles: current status DJ Brayden European Journal of Pharmaceutical Sciences 14 (3), 183-189, 2001 | 128 | 2001 |
| Safety concerns over the use of intestinal permeation enhancers: A mini-review F McCartney, JP Gleeson, DJ Brayden Tissue barriers 4 (2), e1176822, 2016 | 124 | 2016 |
| Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl) amino] caprylate in rat in situ intestinal instillations and in Caco-2 monolayers D Brayden, E Creed, A O'Connell, H Leipold, R Agarwal, A Leone-Bay Pharmaceutical research 14, 1772-1779, 1997 | 119 | 1997 |
Alan BairdUniversity College DublinVerified email at ucd.ie
